Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Ciprofloxacin Inhaled Compared to Placebo in Patients With Non-Cystic Fibrosis Bronchiectasis.

Trial Profile

Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Ciprofloxacin Inhaled Compared to Placebo in Patients With Non-Cystic Fibrosis Bronchiectasis.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Bacterial infections; Bronchiectasis; Respiratory tract infections
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
    • 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
    • 17 May 2011 Results presented at the 107th International Conference of the American Thoracic Society, according to a Bayer Healthcare media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top